{"id":547792,"date":"2021-06-15T17:58:02","date_gmt":"2021-06-15T17:58:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=547792"},"modified":"2021-06-15T17:58:02","modified_gmt":"2021-06-15T17:58:02","slug":"adult-growth-hormone-deficiency-epidemiology-analysis-during-the-study-period-201830-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/adult-growth-hormone-deficiency-epidemiology-analysis-during-the-study-period-201830-by-delveinsight_547792.html","title":{"rendered":"Adult Growth Hormone Deficiency epidemiology analysis during the study period (2018-30) by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1623752735.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Adult Growth Hormone Deficiency epidemiology analysis during the study period (2018-30) by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1623752735.png\" alt=\"Adult Growth Hormone Deficiency epidemiology analysis during the study period (2018-30) by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Adult Growth Hormone Deficiency Epidemiology Forecast<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The &#8216;Adult Growth Hormone Deficiency (AGHD) &#8211; Epidemiology Forecast to 2030&#8217; report from DelveInsight provides an in-depth understanding of the disease, historical and forecasted Adult Growth Hormone Deficiency (AGHD) epidemiology in the 7MM, namely the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/0ce4faa0720a9e5c63d797d5066c3813.jpg\" alt=\"\" \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The <\/span><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/adult-growth-hormone-deficiency-aghd-epidemiology-forecast?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><span>&#8216;<strong>Adult Growth Hormone Deficiency (AGHD) &#8211; Epidemiology Forecast to 2030&#8242;<\/strong><\/span><\/a><span> report from DelveInsight provides an in-depth understanding of the disease, historical and forecasted Adult Growth Hormone Deficiency (AGHD) epidemiology in the 7MM, namely the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some Key Highlights from the Adult Growth Hormone Deficiency Epidemiology Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>According to Jana Bujanova et al., the prevalence of Adult Growth Hormone Deficiency in the UK is estimated to be <\/span><strong>1 in 10,000.<\/strong><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>According to estimates from the Growth Hormone Foundation, over <\/span><strong>50,000<\/strong><span> persons in the United States are growth hormone deficient, with <\/span><strong>6,000<\/strong><span> new instances recorded each year, including GHD children who transition to GHD as an adult.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>According to Akira Shimatsu et al. study, Adult Onset GHD affects a higher percentage of Japanese adults <\/span><span><strong>(80%)<\/strong><\/span><span> than Childhood Onset GHD.<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>To know more, request sample @ <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/adult-growth-hormone-deficiency-aghd-epidemiology-forecast?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Adult Growth Hormone Deficiency Epidemiology<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Adult Growth Hormone Deficiency: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Adult-Onset Growth Hormone Deficiency (AGHD) is a medical condition caused by a lack of growth hormone production in the body. It promotes the production of another hormone known as insulin-like growth factor 1, which is primarily produced by the liver. These hormones work together to promote growth in children and have wide-ranging metabolic impacts in adults.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Adults with GHD are divided into two groups: Childhood Onset (GHD that began in childhood and has since progressed) and Adult Onset (GHD developed after reaching adulthood).<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Adult Growth Hormone Deficiency Epidemiology Segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Adult Growth Hormone Deficiency Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Childhood Onset GHD, Adult Onset GHD Diagnosed Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Adult Growth Hormone Deficiency Gender-Specific Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Adult Growth Hormone Deficiency Diagnosed and Treatable Cases<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For more insights visit, <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/adult-growth-hormone-deficiency-aghd-epidemiology-forecast?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Adult Growth Hormone Deficiency Treatment Approaches<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><strong>Table of Contents<\/strong>&nbsp;<\/span><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"73\" \/>\n<col width=\"551\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><span>1.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Key Insights<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>2.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Adult Growth Hormone Deficiency: Market Overview at a Glance<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>3.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Organisations<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>4.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Executive Summary<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>5.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Methodology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>6.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Adult Growth Hormone Deficiency: Disease Background and Overview<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>7.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>AGHD Epidemiology and Patient Population<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>8.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Total Prevalent Population of Adult Growth Hormone Deficiency in 7MM<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>9.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>AGHD: United States Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>10.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>AGHD: EU5 Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>11.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>AGHD: Japan Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>12.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>SWOT Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>13.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>KOL Views<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>14.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Case studies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>15.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Appendix<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>16.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>17.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>18.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For rich insights into Healthcare and Pharmaceutical News, visit <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Pharma, Healthcare and Biotech Blog Posts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/adult-myopia-epidemiology-forecast?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Adult Myopia Epidemiology Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight&rsquo;s<\/span><span> &lsquo;Adult Myopia&ndash;Epidemiology Forecast&mdash;2030&rsquo;<\/span><span> report delivers an in-depth understanding of the historical and forecasted epidemiology Adult Myopia in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.<\/span>&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=adult-growth-hormone-deficiency-epidemiology-analysis-during-the-study-period-201830-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=adult-growth-hormone-deficiency-epidemiology-analysis-during-the-study-period-201830-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adult Growth Hormone Deficiency Epidemiology Forecast The &#8216;Adult Growth Hormone Deficiency (AGHD) &#8211; Epidemiology Forecast to 2030&#8217; report from DelveInsight provides an in-depth understanding of the disease, historical and forecasted Adult Growth Hormone Deficiency (AGHD) epidemiology in the 7MM, namely &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/adult-growth-hormone-deficiency-epidemiology-analysis-during-the-study-period-201830-by-delveinsight_547792.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,417,406,420,416],"tags":[],"class_list":["post-547792","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Science","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/547792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=547792"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/547792\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=547792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=547792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=547792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}